首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Influence of Glucocorticoids on Glucagon Secretion and Plasma Amino Acid Concentrations in Man
【2h】

Influence of Glucocorticoids on Glucagon Secretion and Plasma Amino Acid Concentrations in Man

机译:糖皮质激素对人体内胰高血糖素分泌和血浆氨基酸浓度的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Plasma concentrations of glucagon, insulin, glucose, and individual plasma amino acids were measured in normal nonobese and obese subjects before and after 3 days of dexamethasone treatment (2 mg/day) and in patients with Cushing's syndrome. The subjects were studied in the basal postabsorptive state and following the infusion of alanine (0.15 g/kg) or ingestion of a protein meal.In nonobese subjects dexamethasone treatment resulted in a 55% increment in basal glucagon levels and in a 60-100% increase in the maximal glucagon response to alanine infusion or protein ingestion. In obese subjects, basal glucagon rose by 110% following dexamethasone, while the response to alanine increased fourfold. In patients with Cushing's syndrome basal glucagon levels were 100% higher and the glucagon response to alanine infusion was 170% greater than in normal controls.Dexamethasone treatment in normal subjects resulted in a 40% rise in plasma alanine concentration which was directly proportional to the rise in basal glucagon. The remaining 14 amino acids were unchanged. In the patients with Cushing's syndrome alanine levels were 40% higher than in normal controls and were directly proportional to basal glucagon concentrations. No other plasma amino acids were significantly altered in the group with Cushing's syndrome.It is concluded that (a) glucocorticoids increase plasma glucagon concentration in the basal state and in response to protein ingestion or aminogenic stimulation; (b) this effect of glucocorticoids occurs in the face of obesity and persists in chronic hypercorticism; (c) hyperalaninemia is a characteristic of acute and chronic glucocorticoid excess, and may in turn contribute to steroid-induced hyperglucagonemia; and (d) increased alpha cell secretion may be a contributory factor in the gluconeogenic and diabetogenic effects of glucocorticoids.
机译:在地塞米松治疗(2 mg /天)3天之前和之后以及库欣综合征患者中,在正常非肥胖和肥胖受试者中测量了胰高血糖素,胰岛素,葡萄糖和各个血浆氨基酸的血浆浓度。对受试者进行了基础吸收后状态的研究以及丙氨酸(0.15 g / kg)的摄入或蛋白质粉的摄入之后的研究。在非肥胖受试者中,地塞米松治疗导致基础胰高血糖素水平增加了55%,在60-100%之间胰高血糖素对丙氨酸或蛋白质摄入的最大反应增加。在肥胖的受试者中,地塞米松治疗后基础胰高血糖素上升了110%,而对丙氨酸的反应则增加了四倍。库欣综合征患者的基础胰高血糖素水平比正常对照组高100%,对丙氨酸输注的胰高血糖素反应比正常对照组高170%。地塞米松治疗导致正常受试者血浆丙氨酸浓度增加40%,与浓度的上升成正比在基底胰高血糖素中。其余14个氨基酸未改变。库欣综合征患者的丙氨酸水平比正常对照组高40%,并且与基础胰高血糖素浓度成正比。结论:(a)糖皮质激素增加了基础状态下的血浆胰高血糖素浓度,并响应于蛋白质的摄入或氨基发生刺激。 (b)糖皮质激素的这种作用发生在肥胖者的脸上,并持续存在于慢性皮质激素过多症中; (c)高丙氨酸血症是急性和慢性糖皮质激素过量的特征,并反过来可能导致类固醇诱导的高血糖素血症; (d)α细胞分泌增加可能是糖皮质激素的糖异生和糖尿病形成作用的一个促成因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号